Product Innovation Revenue Growth
Search documents
Elanco Animal Health Incorporated (ELAN) Presents at 2026 KeyBanc Capital Markets Healthcare Forum Transcript
Seeking Alpha· 2026-03-17 19:22
Core Insights - The company experienced strong growth in key products, particularly Zenrelia and Credelio Quattro, closing the fourth quarter with significant momentum [1] Financial Performance - The company reported revenues of $892 million from its basket of innovation, surpassing expectations and guidance of $840 to $880 million for the year [2] - The revenue forecast for the basket of innovation has been raised from $1.1 billion to $1.15 billion for 2026, reflecting the positive momentum observed through December [2]